Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Response Biomedical's Heart Failure Dx Test

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared a Response Biomedical point-of-care test that serves as an aid in diagnosing heart failure, the company said today.
The RAMP NT-proBNP test identifies the marker for BNP, which is secreted from the heart’s left ventricle in response to pressure overload, and it regulates blood pressure, electrolyte imbalance, and fluid volume.
Elevated levels of the NT-proBNP indicate heart failure, and can be used for early detection and management, according to Vancouver, BC-based Response Biomedical.
The test “supports the drive for speed and accuracy of diagnosis for patients presenting in emergency rooms and for early detection in ambulatory care,” said Response Biomedical CEO S. Wayne Kay.
Kay also said that the test is “clinically concordant” with Roche’s Elecsys proBNP test, allowing hospitals to standardize their decisions based on tests from their emergency rooms and central labs.
Affecting nearly 17 million people worldwide, heart failure is “the single most frequent cause of hospitalization in people over 65 years,” the company said.
Response Biomedical recently granted Roche Diagnostics the rights to market its cardiovascular point-of-care tests.  

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.